Cargando…

Increased osteoclastic activity in acute Charcot’s osteoarthopathy: the role of receptor activator of nuclear factor-kappaB ligand

AIMS/HYPOTHESIS: Our aims were to compare osteoclastic activity between patients with acute Charcot’s osteoarthropathy and diabetic and healthy controls, and to determine the effect of the receptor activator of nuclear factor-kappaB ligand (RANKL) and its decoy receptor osteoprotegerin (OPG). METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mabilleau, G., Petrova, N. L., Edmonds, M. E., Sabokbar, A.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362134/ https://www.ncbi.nlm.nih.gov/pubmed/18389210 http://dx.doi.org/10.1007/s00125-008-0992-1

Ejemplares similares

Effect of Cornus Officinalis on Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL)-induced Osteoclast Differentiation
por: Kim, Jung Young, et al.
Publicado: (2012)

Interleukin-32 Promotes Osteoclast Differentiation but Not Osteoclast Activation
por: Mabilleau, Guillaume, et al.
Publicado: (2009)

Number of Circulating CD14-Positive Cells and the Serum Levels of TNF-α Are Raised in Acute Charcot Foot
por: Mabilleau, Guillaume, et al.
Publicado: (2011)

α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption
por: Kim, Ha-Neui, et al.
Publicado: (2012)

Interleukin-7 Induces Osteoclast Formation via STAT5, Independent of Receptor Activator of NF-kappaB Ligand
por: Kim, Jin-Hee, et al.
Publicado: (2017)

Corrigendum: Interleukin-7 Induces Osteoclast Formation via STAT5, Independent of Receptor Activator of NF-kappaB Ligand
por: Kim, Jin-Hee, et al.
Publicado: (2017)

Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors
por: Yamagishi, Tetsuro, et al.
Publicado: (2016)

Nuclear factor kappaB (NF-kappaB) pathway as a therapeutic target in rheumatoid arthritis.
por: Jue, D. M., et al.
Publicado: (1999)

Nuclear Factor-kappaB in Autoimmunity: Man and Mouse
por: Miraghazadeh, Bahar, et al.
Publicado: (2018)

Activation of nuclear factor-kappaB and not activator protein-1 in cellular response to nickel compounds.
por: Huang, Yi, et al.
Publicado: (2002)

NF-kappaB in Lung Tumorigenesis
por: Cai, Zhenjian, et al.
Publicado: (2011)

Receptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery
por: Friedmann, Anton, et al.
Publicado: (2014)

Low nuclear body formation and tax SUMOylation do not prevent NF-kappaB promoter activation
por: Bonnet, Amandine, et al.
Publicado: (2012)

Receptor Activator of NF-kappaB and Podocytes: Towards a Function of a Novel Receptor-Ligand Pair in the Survival Response of Podocyte Injury
por: Liu, Shuangxin, et al.
Publicado: (2012)

TSG-6 Regulates Bone Remodeling through Inhibition of Osteoblastogenesis and Osteoclast Activation
por: Mahoney, David J., et al.
Publicado: (2008)

Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study
por: Lessard, L, et al.
Publicado: (2005)

Inhibition of NF-kappaB activity in mammary epithelium increases tumor latency and decreases tumor burden
por: Connelly, Linda, et al.
Publicado: (2010)

Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes
por: Gonzales, Amanda M, et al.
Publicado: (2008)

Regulation of Nuclear Factor-kappaB Function by O-GlcNAcylation in Inflammation and Cancer
por: Liu, Angela Rose, et al.
Publicado: (2021)

Inhibition of TNF-α Reverses the Pathological Resorption Pit Profile of Osteoclasts from Patients with Acute Charcot Osteoarthropathy
por: Petrova, Nina L., et al.
Publicado: (2015)

NF-kappaB and cytokines in pancreatic acinar cells.
por: Kim, H, et al.
Publicado: (2000)

NF-kappaB: Two Sides of the Same Coin
por: Pires, Bruno R. B., et al.
Publicado: (2018)

An Update on the Multifaceted Role of NF-kappaB in Endometriosis
por: Liu, Yuanmeng, et al.
Publicado: (2022)

Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
por: Pacifico, Lucia, et al.
Publicado: (2018)

Roles of osteoprotegerin in endocrine and metabolic disorders through receptor activator of nuclear factor kappa-B ligand/receptor activator of nuclear factor kappa-B signaling
por: Zhang, Luodan, et al.
Publicado: (2022)

Artemisia annua extract prevents ovariectomy-induced bone loss by blocking receptor activator of nuclear factor kappa-B ligand-induced differentiation of osteoclasts
por: Lee, Sun Kyoung, et al.
Publicado: (2017)

Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma
por: Yang, David T, et al.
Publicado: (2008)

NF-kappaB activation: Tax sumoylation is out, but what about Tax ubiquitination?
por: Xiao, Gutian
Publicado: (2012)

Role of NF-kappaB2-p100 in regulatory T cell homeostasis and activation
por: Dhar, Atika, et al.
Publicado: (2019)

Regulation of nuclear factor-kappaB in intestinal epithelial cells in a cell model of inflammation.
por: Homaidan, Fadia R, et al.
Publicado: (2003)

Receptor activator of nuclear factor-kappa B is enriched in CD9-positive extracellular vesicles released by osteoclasts
por: Ruan, Shaobo, et al.
Publicado: (2023)

E3 ubiquitin ligase tripartite motif-containing 71 promotes the proliferation of non-small cell lung cancer through the inhibitor of kappaB-α/nuclear factor kappaB pathway
por: Ren, Hongjiu, et al.
Publicado: (2017)

CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis
por: Tsushima, Hidetoshi, et al.
Publicado: (2015)

Eleutherococcus sessiliflorus Inhibits Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Induced Bone Loss
por: Han, Sang-Yong, et al.
Publicado: (2021)

Yukmijihwang-Tang Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Mediated Bone Loss
por: Han, Sang-Yong, et al.
Publicado: (2021)

The Receptor Tyrosine Kinase FGFR4 Negatively Regulates NF-kappaB Signaling
por: Drafahl, Kristine A., et al.
Publicado: (2010)

Recent insights into the role of NF-kappaB in ovarian carcinogenesis
por: Alvero, Ayesha B
Publicado: (2010)

NF-kappaB Signaling in Chronic Inflammatory Airway Disease
por: Schuliga, Michael
Publicado: (2015)

The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis
por: Brown, Keith D, et al.
Publicado: (2008)

Escin Chemosensitizes Human Pancreatic Cancer Cells and Inhibits the Nuclear Factor-kappaB Signaling Pathway
por: Rimmon, A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5fu93t1e6sg3f65lvioem5bh93